株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

医薬品分析試験アウトソーシング市場の分析:サービス(生物学的分析試験、試験方法の開発および検証、安全性テスト)、地域別

Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report By Service (Bioanalytical, Stability Testing, Method Development & Validation), And Segment Forecasts, 2019 - 2026

発行 Grand View Research, Inc. 商品コード 447160
出版日 ページ情報 英文 100 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.55円で換算しております。
Back to Top
医薬品分析試験アウトソーシング市場の分析:サービス(生物学的分析試験、試験方法の開発および検証、安全性テスト)、地域別 Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report By Service (Bioanalytical, Stability Testing, Method Development & Validation), And Segment Forecasts, 2019 - 2026
出版日: 2019年04月05日 ページ情報: 英文 100 Pages
概要

当レポートでは、医薬品分析試験アウトソーシング市場について分析し、基本的な市場構造や、主な市場促進・抑制要因、サービス、地域別の市場動向、収益予測、主要企業のプロファイル、事業戦略などについて調査・考察しております。

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 医薬品分析試験アウトソーシング市場:市場の動向

  • 市場区分と範囲
  • 市場促進要因の分析
  • 浸透・成長見通しのマッピング
  • SWOT分析
  • ファイブフォース分析

第4章 医薬品分析試験アウトソーシング市場:サービス別動向

  • 医薬品分析試験アウトソーシング市場:サービス別市場シェア
  • 市場規模・見通し・動向分析

第5章 医薬品分析試験アウトソーシング市場:地域別動向

  • 医薬品分析試験アウトソーシング市場:地域別市場シェア 2015、2025年
  • 北米(米国、カナダ)
  • 欧州(英国、ドイツ)
  • アジア太平洋(日本、中国)
  • ラテンアメリカ(ブラジル、メキシコ)
  • 中東・アフリカ(南アメリカ)

第6章 競合情勢

  • 戦略の枠組み
  • 企業プロファイル
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Region, 2015 - 2026 (USD Million)
  • Table 4 Global Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 5 North America Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Country, 2015 - 2026 (USD Million)
  • Table 6 North America Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 7 U.S. Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 8 Canada Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 9 Europe Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Country, 2015 - 2026 (USD Million)
  • Table 10 Europe Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 11 U.K. Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 12 Germany Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 13 France Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 14 Italy Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 15 Spain Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 16 Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Country, 2015 - 2026 (USD Million)
  • Table 17 Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 18 Japan Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 19 China Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 20 India Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 21 Thailand Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 22 South Korea Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 23 Latin America Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Country, 2015 - 2026 (USD Million)
  • Table 24 Latin America Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 25 Brazil Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 26 Mexico Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 27 Argentina Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 28 Colombia Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 29 Middle East & Africa Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Country, 2015 - 2026 (USD Million)
  • Table 30 Middle East & Africa Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 31 Saudi Arabia Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 32 South Africa Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 33 UAE Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)

List of Figures

  • Figure 1 Market research process
  • Figure 2 Information procurement
  • Figure 3 Primary research Pharmaceutical analytical testingtern
  • Figure 4 Market research approaches
  • Figure 5 Value chain based sizing and forecasting
  • Figure 6 QFD modelling for market share assessment
  • Figure 7 Pharmaceutical analytical testing Outsourcing market snapshot
  • Figure 8 Pharmaceutical analytical testing Outsourcing market segmentation
  • Figure 9 Pharmaceutical analytical testing Outsourcing market driver impact
  • Figure 10 Pharmaceutical analytical testing Outsourcing market restraint impact
  • Figure 11 Swot analysis, by Factor (Political & Legal, Economic, and Technological)
  • Figure 12 Porter's five forces analysis
  • Figure 13 Pharmaceutical analytical testing Outsourcing: Service outlook and key takeaways
  • Figure 14 Pharmaceutical analytical testing Outsourcing: Service movement analysis
  • Figure 15 Bioanalytical testing market estimates and forecast, 2015 - 2026
  • Figure 16 Clinical market estimates and forecast, 2015 - 2026
  • Figure 17 Non Clinical market estimates and forecast, 2015 - 2026
  • Figure 18 Method Development & Validation market estimates and forecast, 2015 - 2026
  • Figure 19 Extractable & leachable market estimates and forecast, 2015 - 2026
  • Figure 20 Impurity method market estimates and forecast, 2015 - 2026
  • Figure 21 Technical Consulting market estimates and forecast, 2015 - 2026
  • Figure 22 Others market estimates and forecast, 2015 - 2026
  • Figure 23 Stability testing market estimates and forecast, 2015 - 2026
  • Figure 24 Drug substance market estimates and forecast, 2015 - 2026
  • Figure 25 Stability indicating method validation market estimates and forecast, 2015 - 2026
  • Figure 26 Accelerated stability testing market estimates and forecast, 2015 - 2026
  • Figure 27 Photostability testing market estimates and forecast, 2015 - 2026
  • Figure 28 Others market estimates and forecast, 2015 - 2026
  • Figure 29 Others market estimates and forecast, 2015 - 2026
  • Figure 30 Pharmaceutical analytical testing Outsourcing: Regional outlook and key takeaways
  • Figure 31 Pharmaceutical analytical testing Outsourcing: Regional movement analysis
  • Figure 32 North America market estimates and forecast, 2015 - 2026
  • Figure 33 U.S. market estimates and forecast, 2015 - 2026
  • Figure 34 Canada market estimates and forecast, 2015 - 2026
  • Figure 35 Europe market estimates and forecast, 2015 - 2026
  • Figure 36 U.K. market estimates and forecast, 2015 - 2026
  • Figure 37 Germany market estimates and forecast, 2015 - 2026
  • Figure 38 France market estimates and forecast, 2015 - 2026
  • Figure 39 Italy market estimates and forecast, 2015 - 2026
  • Figure 40 Spain market estimates and forecast, 2015 - 2026
  • Figure 41 Asia Pacific market estimates and forecast, 2015 - 2026
  • Figure 42 Japan market estimates and forecast, 2015 - 2026
  • Figure 43 China market estimates and forecast, 2015 - 2026
  • Figure 44 India market estimates and forecast, 2015 - 2026
  • Figure 45 Thailand market estimates and forecast, 2015 - 2026
  • Figure 46 South Korea market estimates and forecast, 2015 - 2026
  • Figure 47 Latin America market estimates and forecast, 2015 - 2026
  • Figure 48 Brazil market estimates and forecast, 2015 - 2026
  • Figure 49 Mexico market estimates and forecast, 2015 - 2026
  • Figure 50 Argentina market estimates and forecast, 2015 - 2026
  • Figure 51 Colombia market estimates and forecast, 2015 - 2026
  • Figure 52 Middle East & Africa market estimates and forecast, 2015 - 2026
  • Figure 53 Saudi Arabia market estimates and forecast, 2015 - 2026
  • Figure 54 South Africa market estimates and forecast, 2015 - 2026
  • Figure 55 UAE market estimates and forecast, 2015 - 2026
目次
Product Code: GVR-1-68038-365-2

The global pharmaceutical analytical testing outsourcing market size is projected to reach USD 10.4 billion by 2026 expanding at a CAGR of 8.1%, according to a new report by Grand View Research, Inc. Focus on the analytical testing of biopharmaceuticals and biosimilars, adoption of Full Time Equivalent Agreements (FTE), and increased outsourcing of analytical testing services to contract pharma companies are propelling the market growth. Demand for biosimilars and pharmaceutical drugs is expected to increase substantially over the forecast period. Thus, to fulfill the rising demand, key pharmaceutical companies and government bodies are working collaboratively.

For instance, in August 2018, the Swedish government collaborated with GE Healthcare to establish a new innovation center for testing of new discoveries in the pharmaceutical sector. Major companies may lack the required manufacturing set-up and expertise to carry out in-house testing services. This leads to the outsourcing of in-house work to contract pharmaceutical companies. In addition, several ancillary works, such as registration, storage and testing, process and facility validation, and cleaning validations, are outsourced to remain competitive in the market. These factors will boost the market growth in the years to come.

Further key findings from the study suggest:

Clinical bioanalytical testing services is projected to be the largest service segment over the forecast period

Increasing number of clinical trial registrations and entry of new contract pharma companies are the factors responsible for the segment growth

North America led the global pharmaceutical analytical testing outsourcing market in 2018 due to government support and strong presence of key pharmaceutical outsourcing companies

Some of the key companies in the market are SGS SA; Intertek Group PLC; Pharmaceutical Product Development, LLC; Toxikon, Inc.; Exova Group PLC, Eurofins Scientific; Pace Analytical Services, LLC; Charles River Laboratories International, Inc.; Boston Analytical, Inc.; and West Pharmaceutical Services, Inc.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market segmentation & scope
  • 1.2 Information procurement
    • 1.2.1 Purchased database
    • 1.2.2 GVR's internal database
    • 1.2.3 Secondary sources & third party perspectives
    • 1.2.4 Primary research
  • 1.3 Information analysis
    • 1.3.1 Data analysis models
  • 1.4 Market formulation & data visualization
  • 1.5 Data validation & publishing

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights

Chapter 3 Pharmaceutical Analytical Testing Outsourcing Market Variables, Trends & Scope

  • 3.1 Market Lineage outlook
    • 3.1.1 Parent market outlook
    • 3.1.2 Related/ancillary market outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Product Pipeline Analysis, by Stage
  • 3.4 User perspective analysis
    • 3.4.1 Consumer Behavior Analysis
    • 3.4.2 Market Influencer Analysis
  • 3.5 List of Key End-users, by region / by product / by country
  • 3.6 Regulatory Framework
    • 3.6.1 Reimbursement framework
    • 3.6.2 Standards & Compliances
  • 3.7 Market Dynamics
    • 3.7.1 Market Driver Analysis
      • 3.7.1.1 Innovation
      • 3.7.1.2 Regulatory safety and quality
      • 3.7.1.3 End users volume
    • 3.7.2 Market Restraint Analysis
      • 3.7.2.1 Data security
      • 3.7.2.2 Third party performance
    • 3.7.3 Industry Challenges
      • 3.7.3.1 Implementation issues
  • 3.8 Pharmaceutical Analytical Testing Outsourcing: Market Analysis Tools
    • 3.8.1 Industry Analysis - Porter's
      • 3.8.1.1 Supplier Power
      • 3.8.1.2 Buyer Power
      • 3.8.1.3 Substitution Threat
      • 3.8.1.4 Threat from new entrant
      • 3.8.1.5 Competitive rivalry
    • 3.8.2 PESTEL Analysis
      • 3.8.2.1 Political Landscape
      • 3.8.2.2 Environmental Landscape
      • 3.8.2.3 Social Landscape
      • 3.8.2.4 Technology Landscape
      • 3.8.2.5 Legal Landscape
    • 3.8.3 Major Deals & Strategic Alliances Analysis
      • 3.8.3.1 Joint Ventures
      • 3.8.3.2 Mergers & Acquisitions
      • 3.8.3.3 Licensing & Partnership
      • 3.8.3.4 Technology Collaborations
      • 3.8.3.5 Strategic Divestments
    • 3.8.4 Market Entry Strategies

Chapter 4 Pharmaceutical Analytical Testing Outsourcing Market: Segment Analysis, By Service, 2015 - 2026 (USD Million)

  • 4.1 Definitions & Scope
  • 4.2 Services market share analysis, 2018 & 2026
  • 4.3 Segment Dashboard
  • 4.4 Global Pharmaceutical Analytical Testing Outsourcing Market, by Service, 2015 to 2026
  • 4.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
    • 4.5.1 Bioanalytical Testing
      • 4.5.1.1 Clinical
      • 4.5.1.2 Non-clinical
    • 4.5.2 Method Development & Validation
      • 4.5.2.1 Other regulatory services
      • 4.5.2.2 Extractable & Leachable
      • 4.5.2.3 Impurity Method
      • 4.5.2.4 Technical Consulting
      • 4.5.2.5 Others
    • 4.5.3 Stability Testing
      • 4.5.3.1 Drug Substance
      • 4.5.3.2 Stability Indicating Method Validation
      • 4.5.3.3 Accelerated Stability Testing
      • 4.5.3.4 Photo-stability Testing
      • 4.5.3.5 Others
    • 4.5.4 Others

Chapter 5 Pharmaceutical Analytical Testing Outsourcing Market: Regional Market Analysis, 2015 - 2026 (USD Million)

  • 5.1 Definitions & Scope
  • 5.2 Regional market share analysis, 2018 & 2026
  • 5.3 Regional Market Dashboard
  • 5.4 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
  • 5.5 Regional Market Share and Leading Players, 2018
    • 5.5.1 North America
    • 5.5.2 Europe
    • 5.5.3 Asia Pacific
    • 5.5.4 Latin America
    • 5.5.5 Middle East & Africa
  • 5.6 SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
    • 5.6.1 North America
    • 5.6.2 Europe
    • 5.6.3 Asia Pacific
    • 5.6.4 Latin America
    • 5.6.5 Middle East & Africa
  • 5.7 Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2026:
  • 5.8 North America
    • 5.8.1 Market estimates and forecast, by country, 2015 - 2026 (USD Million)
    • 5.8.2 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
    • 5.8.3 U.S.
      • 5.8.3.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
    • 5.8.4 Canada
      • 5.8.4.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
  • 5.9 Europe
    • 5.9.1 Market estimates and forecast, by country, 2015 - 2026 (USD Million)
    • 5.9.2 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
    • 5.9.3 Germany
      • 5.9.3.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
    • 5.9.4 U.K.
      • 5.9.4.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
    • 5.9.5 France
      • 5.9.5.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
    • 5.9.6 Italy
      • 5.9.6.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
    • 5.9.7 Spain
      • 5.9.7.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
  • 5.10 Asia Pacific
    • 5.10.1 Market estimates and forecast, by country, 2015 - 2026 (USD Million)
    • 5.10.2 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
    • 5.10.3 China
      • 5.10.3.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
    • 5.10.4 Japan
      • 5.10.4.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
    • 5.10.5 India
      • 5.10.5.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
    • 5.10.6 Thailand
      • 5.10.6.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
    • 5.10.7 South Korea
      • 5.10.7.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
  • 5.11 Latin America
    • 5.11.1 Market estimates and forecast, by country, 2015 - 2026 (USD Million)
    • 5.11.2 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
    • 5.11.3 Brazil
      • 5.11.3.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
    • 5.11.4 Mexico
      • 5.11.4.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
    • 5.11.5 Argentina
      • 5.11.5.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
    • 5.11.6 Colombia
      • 5.11.6.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
  • 5.12 Middle East & Africa
    • 5.12.1 Market estimates and forecast, by country, 2015 - 2026 (USD Million)
    • 5.12.2 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
    • 5.12.3 South Africa
      • 5.12.3.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
    • 5.12.4 Saudi Arabia
      • 5.12.4.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
    • 5.12.5 UAE
      • 5.12.5.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)

Chapter 6 Pharmaceutical Analytical Testing Outsourcing Market - Competitive Analysis

  • 6.1 Recent developments & impact analysis, by key market participants
  • 6.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 6.3 Vendor Landscape
    • 6.3.1 List of key distributors and channel partners
    • 6.3.2 Key customers
    • 6.3.3 Key company market share analysis, 2018
  • 6.4 Public Companies
    • 6.4.1 Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
    • 6.4.2 Company Market Share/Ranking, by region
    • 6.4.3 Competitive Dashboard Analysis
      • 6.4.3.1 Market Differentiators
      • 6.4.3.2 Synergy Analysis: Major Deals & Strategic Alliances
  • 6.5 Private Companies
    • 6.5.1 List of key emerging companies' /technology disruptors/innovators
    • 6.5.2 Funding Outlook (Optional)
    • 6.5.3 Regional network map
    • 6.5.4 Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
  • 6.6 Supplier Ranking
  • 6.7 Key companies profiled
    • 6.7.1 SGS SA
      • 6.7.1.1 Company Overview
      • 6.7.1.2 Financial Performance
      • 6.7.1.3 Product Benchmarking
      • 6.7.1.4 Strategic Initiatives
    • 6.7.2 Toxikon, Inc.
      • 6.7.2.1 Company Overview
      • 6.7.2.2 Financial Performance
      • 6.7.2.3 Product Benchmarking
      • 6.7.2.4 Strategic Initiatives
    • 6.7.3 Eurofins Scientific
      • 6.7.3.1 Company Overview
      • 6.7.3.2 Financial Performance
      • 6.7.3.3 Product Benchmarking
      • 6.7.3.4 Strategic Initiatives
    • 6.7.4 Pace Analytical Services LLC.
      • 6.7.4.1 Company Overview
      • 6.7.4.2 Financial Performance
      • 6.7.4.3 Product Benchmarking
      • 6.7.4.4 Strategic Initiatives
    • 6.7.5 Intertek Group plc
      • 6.7.5.1 Company Overview
      • 6.7.5.2 Financial Performance
      • 6.7.5.3 Product Benchmarking
      • 6.7.5.4 Strategic Initiatives
    • 6.7.6 Pharmaceutical Product Development, LLC.
      • 6.7.6.1 Company Overview
      • 6.7.6.2 Financial Performance
      • 6.7.6.3 Product Benchmarking
      • 6.7.6.4 Strategic Initiatives
    • 6.7.7 Exova Group plc.
      • 6.7.7.1 Company Overview
      • 6.7.7.2 Financial Performance
      • 6.7.7.3 Product Benchmarking
      • 6.7.7.4 Strategic Initiatives
    • 6.7.8 Boston Analytical
      • 6.7.8.1 Company Overview
      • 6.7.8.2 Financial Performance
      • 6.7.8.3 Product Benchmarking
      • 6.7.8.4 Strategic Initiatives
    • 6.7.9 Charles River Laboratories International, Inc.
      • 6.7.9.1 Company Overview
      • 6.7.9.2 Financial Performance
      • 6.7.9.3 Product Benchmarking
      • 6.7.9.4 Strategic Initiatives
    • 6.7.10 West Pharmaceutical Services
      • 6.7.10.1 Company Overview
      • 6.7.10.2 Financial Performance
      • 6.7.10.3 Product Benchmarking
      • 6.7.10.4 Strategic Initiatives

Chapter 7 KOL Commentary

Chapter 8 Recommendations

Back to Top